Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) ...

For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is expected at 16-24% growth. However, this forecast, 3% lower for revenue and ...

There are significant questions on how the order can be implemented, and if companies can raise prices on already approved ...

The ALS therapy ATLX-1282 was developed with AIchemab's platform, which uses AI to identify therapeutic targets for difficult ...

Zepbound — the brand name for tirzepatide — is the most effective GLP-1 medication for weight loss, according to one study.

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

The US is the biggest market for prescription drugs, accounting for roughly $600bn of annual sales out of a global $1tn or so ...

Viking Therapeutics became famous in the biotech world last year after announcing positive phase 2 results for VK2735, an investigational GLP-1 weight loss candidate. The stock has not performed well ...

A survey of adults living with obesity and their physicians across seven countries reveals a high disconnect between their perceptions about the ...

In the first direct comparison study involving individuals with obesity, tirzepatide demonstrated approximately 50% greater ...

The best metric is not weight, but a particularly toxic kind of fat.